ACAD
18.26
+0.71
+4.05%
AEMD
4.84
-0.56
-10.37%
APRI
1.14
-0.03
-2.56%
ARNA
1.52
+0.05
+3.40%
ATEC
0.205
-0.004
-1.914%
CNAT
1.73
+0.08
+4.85%
CRXM
0.2
-0.03
-12.28%
CYTX
0.133
0.00
0.00%
DXCM
56.12
-0.13
-0.23%
GNMK
4.78
-0.26
-5.16%
HALO
7.54
+0.11
+1.48%
ILMN
142.72
+4.26
+3.08%
INNV
0.06
+0.01
+20.00%
INO
6.27
+0.08
+1.29%
ISCO
2.44
-0.17
-6.51%
ISIS
57.56
0.00
0.00%
LGND
85.97
+0.18
+0.21%
LPTN
0.156
+0.00
+0.0644%
MBVX
0.53
0.00
+0.23%
MEIP
1.04
-0.02
-1.89%
MNOV
4.19
-0.03
-0.71%
MRTX
20.11
+0.72
+3.71%
MSTX
0.256
+0.021
+8.7197%
NBIX
36.04
+0.67
+1.89%
NUVA
39.12
-2.7
-6.46%
ONCS
1.68
+0.17
+11.26%
ONVO
1.89
-0.04
-2.07%
OREX
1.64
-0.01
-0.61%
OTIC
14.33
+0.37
+2.65%
QDEL
14.99
-0.29
-1.90%
RCPT
231.96
0.00
0.00%
RGLS
5.84
-0.01
-0.17%
RMD
57.88
+0.76
+1.33%
SCIE
0.001
+0.00
+14.2857%
SPHS
1.58
+0.01
+0.64%
SRNE
5.52
+0.63
+12.88%
TROV
3.76
-0.15
-3.84%
VICL
0.305
-0.015
-4.6904%
VOLC
18
0.00
0.00%
ZGNX
9.79
+0.27
+2.84%
ACAD
18.26
+0.71
+4.05%
AEMD
4.84
-0.56
-10.37%
APRI
1.14
-0.03
-2.56%
ARNA
1.52
+0.05
+3.40%
ATEC
0.205
-0.004
-1.914%
CNAT
1.73
+0.08
+4.85%
CRXM
0.2
-0.03
-12.28%
CYTX
0.133
0.00
0.00%
DXCM
56.12
-0.13
-0.23%
GNMK
4.78
-0.26
-5.16%
HALO
7.54
+0.11
+1.48%
ILMN
142.72
+4.26
+3.08%
INNV
0.06
+0.01
+20.00%
INO
6.27
+0.08
+1.29%
ISCO
2.44
-0.17
-6.51%
ISIS
57.56
0.00
0.00%
LGND
85.97
+0.18
+0.21%
LPTN
0.156
+0.00
+0.0644%
MBVX
0.53
0.00
+0.23%
MEIP
1.04
-0.02
-1.89%
MNOV
4.19
-0.03
-0.71%
MRTX
20.11
+0.72
+3.71%
MSTX
0.256
+0.021
+8.7197%
NBIX
36.04
+0.67
+1.89%
NUVA
39.12
-2.7
-6.46%
ONCS
1.68
+0.17
+11.26%
ONVO
1.89
-0.04
-2.07%
OREX
1.64
-0.01
-0.61%
OTIC
14.33
+0.37
+2.65%
QDEL
14.99
-0.29
-1.90%
RCPT
231.96
0.00
0.00%
RGLS
5.84
-0.01
-0.17%
RMD
57.88
+0.76
+1.33%
SCIE
0.001
+0.00
+14.2857%
SPHS
1.58
+0.01
+0.64%
SRNE
5.52
+0.63
+12.88%
TROV
3.76
-0.15
-3.84%
VICL
0.305
-0.015
-4.6904%
VOLC
18
0.00
0.00%
ZGNX
9.79
+0.27
+2.84%
Home » Archive by Category

Xconomy

With $100M, Guardant Health to Expand Reach of Blood Test for Cancer

January 7, 2016 – 5:30 am

We’ve all heard that dust is at least partly made up of dead skin cells. However true or untrue that may be, living tissue that is growing rapidly, such as a cancerous solid tumor, does indeed shed…

[[Click headline to continue reading.]]

From Ambitions To Markets: Richard Kitney And More Synthetic Bio Views

January 6, 2016 – 4:30 am

Last week, Xconomy ran the first part of my conversation with Richard Kitney, a bioengineering professor at Imperial College London and a pioneer in the field of synthetic biology. We met in his…

[[Click headline to continue reading.]]

NuVasive Buys Skeletal Specialist in First Deal under New CEO

January 5, 2016 – 6:55 pm

San Diego’s NuVasive (NASDAQ: NUVA), a medical device maker that specializes in spinal procedures, said today it is acquiring privately held Ellipse Technologies for $380 million in cash, with an…

[[Click headline to continue reading.]]

Formerly Atterocor, Millendo Changes Name, Strategy—And Nabs $62M

January 5, 2016 – 5:00 am

When a biotech company with one product in development misses its milestones, investors typically don’t throw more money at it. Not so with the newly renamed Millendo Therapeutics. The Ann…

[[Click headline to continue reading.]]

Oncology’s Future: Liquid Biopsies and the Heterogeneity of Cancer

January 5, 2016 – 2:00 am

We have known for some time that cancer is not a static, monolithic disease. Instead, we now think of cancer as heterogeneous. Each patient’s cancer may arise from widely dissimilar origins, even in…

[[Click headline to continue reading.]]

Lab Space on a Navy Ship, And Other Creative Solutions for NY Biotech

January 4, 2016 – 10:01 pm

I was a management consultant in a former life, and was trained in that role to always have three arguments to support any conclusion. But having spent the last six months living and breathing…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]

Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1

December 31, 2015 – 3:00 am

“Synthetic biology” has always been a puzzling term to me. Prosthetic limbs are synthetic. Knee replacements are synthetic. Splicing the gene from one organism into another, a practice…

[[Click headline to continue reading.]]